April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Monocytes/macrophages alter the blood-retinal barrier by secretion of cytokines and growth factors in diabetic retinopathy
Author Affiliations & Notes
  • Finny Monickaraj
    Surgery/Opthalmology, University of New Mexico, Albuquerque, NM
  • Carolina Franco Nitta
    Surgery/Opthalmology, University of New Mexico, Albuquerque, NM
    Surgery, NMVA Health Care System, Albuquerque, NM
  • Amy Lucero
    Cell Biology and Physiology, University of New Mexico, Albuquerque, NM
  • Paul McGuire
    Surgery/Opthalmology, University of New Mexico, Albuquerque, NM
    Cell Biology and Physiology, University of New Mexico, Albuquerque, NM
  • Arup Das
    Surgery/Opthalmology, University of New Mexico, Albuquerque, NM
    Surgery, NMVA Health Care System, Albuquerque, NM
  • Footnotes
    Commercial Relationships Finny Monickaraj, None; Carolina Franco Nitta, None; Amy Lucero, None; Paul McGuire, None; Arup Das, Genentech (F), Novartis (R), Regeneron (R), Teva (R)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5825. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Finny Monickaraj, Carolina Franco Nitta, Amy Lucero, Paul McGuire, Arup Das; Monocytes/macrophages alter the blood-retinal barrier by secretion of cytokines and growth factors in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5825.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We have previously shown that chronic hyperglycemia results in upregulation of chemotactic factors (CCL2/MCP-1) leading to recruitment of monocytes/macrophages in the retina. In this study, we examined how monocyte/macrophages result in expression of cytokines and chemokines that result in breakdown of the blood-retinal barrier.

Methods: Human retinal endothelial cells (HREC) were used as in vitro model. The cells were treated with 20% of macrophage conditioned media (CM) (U937 cells and peripheral blood mononucleated cells, PBMCs stimulated with PMA) along with the 80% of growth medium for 48hrs. RNA was extracted from the treated cells and CCL2, CCL5, CCL7, Ang2, ICAM, VCAM expression were analyzed. Secreted CCL2 levels in the medium were measured by ELISA. Monocyte adhesion was monitored using fluorescently labeled U937 cells, transendothelial resistance in the cells was measured by ECIS. Stress actin fibers were imaged using confocal microscopy.

Results: The HREC treated with macrophage conditioned media demonstrated a significantly increased expression for CCL2, CCL5, CCL7, Ang2, ICAM and VCAM (p<0.05). There was a significantly increased secretion of CCL2. In response to macrophage CM, the adhesion of monocytes in the treated cells was increased in comparison to untreated cells (p<0.01). Transendothelial resistance significantly decreased in HREC treated with macrophage CM (p<0.01). Stress actin fiber formation suggestive of barrier alteration was seen in treated cells.

Conclusions: In this study we have shown that monocytes/macrophages recruited into the retina in response to diabetes facilitates the breakdown of the BRB through the secretion of cytokines and chemokines that modify the interendothelial cell junctions.

Keywords: 499 diabetic retinopathy • 490 cytokines/chemokines • 557 inflammation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×